Adalimumab vs Doxycycline

## Adalimumab vs Doxycycline: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Doxycycline**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Doxycycline**: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Doxycycline — 18-22 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Doxycycline — C22H24N2O8.

**Molecular Weight**: Adalimumab — N/A; Doxycycline — 444.4350 g/mol.

**Type**: Adalimumab — Antibody; Doxycycline — Small molecule.